SEC Form 4 · accession 0001225208-18-015757
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Link Ph.D.
Director
Period of report
Nov 19, 2018
Accepted (ET)
Nov 20, 2018 · 8:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 31, 2018 | G | 10,000 | $0.00 | D | 16,730 | D | |
| Common StockF2 | Nov 19, 2018 | S | 2,628 | $150.0624 | D | 6,372 | I | Link Family Enterprise, LP |
| Common StockF2 | Aug 31, 2018 | G | 10,000 | $0.00 | A | 17,000 | I | Link Family Trust |
| Common Stock | Nov 19, 2018 | S | 10,950 | $149.8816 | D | 6,050 | I | Link Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $150.03 to $150.13. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- F2Includes shares that were previously aggregated with other shares reported as held indirectly.
- F3This transaction was executed in multiple trades at prices ranging from $149.68 to $150.39. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Remarks
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.